People · Operator
Named in public records as an officer, director or promoter · active 2013–2014 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Moderna LLC | — | Pharmaceuticals | Growth/Late | $691.1M | $16.2B | 2013 |
| Vero Biotech Inc. | — | Pharmaceuticals | Series B | $82.1M | $525.6M | 2013 |
Theo Melas-Kyriazi at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Theo Melas-Kyriazi on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Robert Langer | 1 | 36 |
| Noubar Afeyan | 1 | 9 |
| Todd Brady | 1 | 7 |
| James O'Brien | 1 | 5 |
| Lee Babiss | 1 | 5 |
| Lorence Kim | 1 | 5 |
| Robert Carpenter | 1 | 5 |
| Stephane Bancel | 1 | 4 |
| John Mendlein | 1 | 4 |
| PETER HUTT | 1 | 4 |
| Henri Termeer | 1 | 3 |
| Steven Shulman | 1 | 3 |
| James Kasinger | 1 | 2 |
| Anthony Loumidis | 1 | 2 |
| Paul Scott Antinori | 1 | 2 |
| Daniel Salazar | 1 | 2 |
| T. Scott Johnson, M.D. | 1 | 1 |
| David Fine | 1 | 1 |
| Thiago V. Tavares | 1 | 1 |
| Shasha V. Zou | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.